Secondary Logo

Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

ARTICLE

Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium

Narula, Neeraj MD, MPH1,2; Peerani, Farhad MD1,3; Meserve, Joseph MD4; Kochhar, Gursimran MD5; Chaudrey, Khadija MD6; Hartke, Justin MD7; Chilukuri, Prianka MD7; Koliani-Pace, Jenna MD8; Winters, Adam MD1; Katta, Leah MD1; Shmidt, Eugenia MD1; Hirten, Robert MD1,9; Faleck, David MD1; Parikh, Malav P. MD5; Whitehead, Diana MD8; Boland, Brigid S. MD4; Singh, Siddharth MD, MS4; Sagi, Sashidhar Varma MD7; Fischer, Monika MD7; Chang, Shannon MD10; Barocas, Morris MD11; Luo, Michelle MS, PhD11; Lasch, Karen MD11; Bohm, Matthew MD7; Lukin, Dana MD12; Sultan, Keith MD9; Swaminath, Arun MD13; Hudesman, David MD10; Gupta, Nitin MD14; Shen, Bo MD5; Kane, Sunanda MD6; Loftus, Edward V. MD6; Siegel, Corey A. MD8; Sands, Bruce E. MD1; Colombel, Jean-Frederic MD1; Sandborn, William J. MD4; Dulai, Parambir S. MD4

Author Information
American Journal of Gastroenterology: September 2018 - Volume 113 - Issue 9 - p 1345
doi: 10.1038/s41395-018-0162-0
  • Buy

Abstract

© The American College of Gastroenterology 2018. All Rights Reserved.